Peripheral T Cell Lymphoma

Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Study of Lacutamab in Peripheral T-cell Lymphoma

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR

Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy

Circulating Tumor DNA Sequencing in Patients With Peripheral T-cell Lymphomas

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study

A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Evaluate the Safety and Clinical Activity of HH2853

A Study of Bosmolisib (BR101801) in Participants With R/R PTCL.

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies